ArticleClinical rheumatology2025
Severe infection risk in triple and quadruple therapy for anti-MDA5 antibody-positive dermatomyositis.
Yoshitaka Ueda et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleClinical rheumatology2025
Yoshitaka Ueda et al.PubMed ↗Publisher ↗
No numbers read from the abstract.